Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer

被引:1104
作者
Carver, Brett S. [1 ,2 ,3 ]
Chapinski, Caren [1 ,2 ,3 ]
Wongvipat, John [1 ]
Hieronymus, Haley [1 ]
Chen, Yu [1 ,4 ]
Chandarlapaty, Sarat [4 ]
Arora, Vivek K. [1 ,4 ]
Le, Carl [5 ]
Koutcher, Jason [4 ,5 ]
Scher, Howard [4 ]
Scardino, Peter T. [2 ,3 ]
Rosen, Neal [4 ]
Sawyers, Charles L. [1 ,4 ,6 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA
[3] Mem Sloan Kettering Canc Ctr, Div Urol, New York, NY 10065 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10065 USA
[6] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA
关键词
DUAL PI3K/MTOR INHIBITOR; HORMONAL-THERAPY; TUMOR-SUPPRESSOR; PATHWAY; KINASE; MTOR; CELLS; INDUCTION; TARGET; PHOSPHATASE;
D O I
10.1016/j.ccr.2011.04.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Prostate cancer is characterized by its dependence on androgen receptor (AR) and frequent activation of PI3K signaling. We find that AR transcriptional output is decreased in human and murine tumors with PTEN deletion and that PI3K pathway inhibition activates AR signaling by relieving feedback inhibition of HER kinases. Similarly, AR inhibition activates AKT signaling by reducing levels of the AKT phosphatase PHLPP. Thus, these two oncogenic pathways cross-regulate each other by reciprocal feedback. Inhibition of one activates the other, thereby maintaining tumor cell survival. However, combined pharmacologic inhibition of PI3K and AR signaling caused near-complete prostate cancer regressions in a Pten-deficient murine prostate cancer model and in human prostate cancer xenografts, indicating that both pathways coordinately support survival.
引用
收藏
页码:575 / 586
页数:12
相关论文
共 46 条
[41]
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer [J].
Tran, Chris ;
Ouk, Samedy ;
Clegg, Nicola J. ;
Chen, Yu ;
Watson, Philip A. ;
Arora, Vivek ;
Wongvipat, John ;
Smith-Jones, Peter M. ;
Yoo, Dongwon ;
Kwon, Andrew ;
Wasielewska, Teresa ;
Welsbie, Derek ;
Chen, Charlie Degui ;
Higano, Celestia S. ;
Beer, Tomasz M. ;
Hung, David T. ;
Scher, Howard I. ;
Jung, Michael E. ;
Sawyers, Charles L. .
SCIENCE, 2009, 324 (5928) :787-790
[42]
Pten dose dictates cancer progression in the prostate [J].
Trotman, LC ;
Niki, M ;
Dotan, ZA ;
Koutcher, JA ;
Di Cristofano, A ;
Xiao, A ;
Khoo, AS ;
Roy-Burman, P ;
Greenberg, NM ;
Van Dyke, T ;
Cordon-Cardo, C ;
Pandolfi, PP .
PLOS BIOLOGY, 2003, 1 (03) :385-396
[43]
Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival [J].
Wang, Y. ;
Mikhailova, M. ;
Bose, S. ;
Pan, C-X ;
White, Rw deVere ;
Ghosh, P. M. .
ONCOGENE, 2008, 27 (56) :7106-7117
[44]
Suppression of HER2/HER3-Mediated Growth of Breast Cancer Cells with Combinations of GDC-0941 PI3K Inhibitor, Trastuzumab, and Pertuzumab [J].
Yao, Evelyn ;
Zhou, Wei ;
Lee-Hoeflich, Si Tuen ;
Truong, Tom ;
Haverty, Peter M. ;
Eastham-Anderson, Jeffrey ;
Lewin-Koh, Nicholas ;
Gunter, Bert ;
Belvin, Marcia ;
Murray, Lesley J. ;
Friedman, Lori S. ;
Sliwkowski, Mark X. ;
Hoeflich, Klaus P. .
CLINICAL CANCER RESEARCH, 2009, 15 (12) :4147-4156
[45]
From HER2/Neu signal cascade to androgen receptor and its coactivators: A novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells [J].
Yeh, SY ;
Lin, HK ;
Kang, HY ;
Thin, TH ;
Lin, MF ;
Chang, CS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) :5458-5463
[46]
Inhibition of Tumor Growth Progression by Antiandrogens and mTOR Inhibitor in a Pten-Deficient Mouse Model of Prostate Cancer [J].
Zhang, Weisheng ;
Zhu, Joe ;
Efferson, Clay L. ;
Ware, Chris ;
Tammam, Jennifer ;
Angagaw, Minilik ;
Laskey, Jason ;
Bettano, Kimberly A. ;
Kasibhatla, Shailaja ;
Reilly, John F. ;
Sur, Cyrille ;
Majumder, Pradip K. .
CANCER RESEARCH, 2009, 69 (18) :7466-7472